{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:35:05Z","timestamp":1791142505869,"version":"4.1.0"},"reference-count":0,"publisher":"American Society for Clinical Investigation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Invest."],"published-print":{"date-parts":[[1990,3,1]]},"DOI":"10.1172\/jci114483","type":"journal-article","created":{"date-parts":[[2008,2,28]],"date-time":"2008-02-28T21:22:29Z","timestamp":1204233749000},"page":"620-625","source":"Crossref","is-referenced-by-count":135,"title":["Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies."],"prefix":"10.1172","volume":"85","author":[{"given":"G","family":"Dietrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M D","family":"Kazatchkine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jci.org\/articles\/view\/114483\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:20:01Z","timestamp":1691079601000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jci.org\/articles\/view\/114483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,3,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1990,3,1]]}},"URL":"https:\/\/doi.org\/10.1172\/jci114483","relation":{},"ISSN":["0021-9738"],"issn-type":[{"value":"0021-9738","type":"print"}],"subject":[],"published":{"date-parts":[[1990,3,1]]}}}